The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
GOBLET: A phase 1/2 multiple-indication biomarker, safety, and efficacy study in advanced or metastatic gastrointestinal cancers exploring treatment combinations with pelareorep and atezolizumab.
 
Dirk Arnold
Honoraria - Bayer; Bristol-Myers Squibb; Merck Serono; Merck Sharp and Dome; Roche/Genentech; SERVIER; TERUMO
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Bayer; Biocompatibles; Bristol-Myers Squibb; Merck Serono; MSD Oncology; Servier; Terumo
Research Funding - Roche/Genentech (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche/Genentech
 
Maike Collienne
No Relationships to Disclose
 
Grey A Wilkinson
Employment - Oncolytics
Stock and Other Ownership Interests - Oncolytics
Patents, Royalties, Other Intellectual Property - Patents
 
Houra Loghmani
Employment - Oncolytics
Stock and Other Ownership Interests - Oncolytics
Research Funding - Oncolytics
Travel, Accommodations, Expenses - Oncolytics
 
Thomas Charles Heineman
Employment - Denovo Biopharma; Oncolytics
Leadership - Oncolytics
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie; Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Halozyme; Johnson & Johnson/Janssen; Oncolytics; Pfizer; Takeda
Consulting or Advisory Role - Moderna Therapeutics
Patents, Royalties, Other Intellectual Property - Halozyme: PCT/US19/32537 Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble PH20 Genocea: PCT/US 62/855,309; PCT/US 62/848,527 Methods of identifying and/or selecting antigens that improve, increase and/or s